Company management

CEO & Chairman of the Executive Board: Professor Dr Michael A. Popp

Prof Dr Michael A. Popp

In 1988, the then 28-year-old pharmacist, Michael A. Popp, took over the management of the company founded by his grandfather Josef Popp and systematically followed the family company's chosen course. He positioned the company as one of the leading manufacturers of herbal medicines worldwide and coined the term Phytoneering. This term expresses the link between the medicinal efficacy of plants and the potential of modern pharmaceutical research. In this process, intensive research as well as the determination of efficacy, quality and safety of the medicines are the core values of the company.

Today, global expansion is being driven forward under his leadership - with turnover multiplying. Bionorica has become a global player.


Global Head of Finance and IT and Member of the Executive Board: Dr Michael A. Rödel

Dr Michael Rödel

Since 2007 Dr Michael A. Rödel fills the position Global Head of Finance at Bionorica SE. Dr Michael A. Rödel has a PhD in economics and has held long-term leading positions in medium-sized companies oriented towards both national and international markets.

The finance department at Bionorica SE is being aligned with international standards under his leadership and the structures for strong global growth are thus being put in place.


Global Head of Product Supply and Member of the Executive Board: Dr Hanke Wohlers

Dr Hanke Wohlers

Since 2019 Dr Hanke Wohlers is part of the management team as Global Head of Product Supply. The pharmacist startet at Bionorica as Manager of Product Supply in 2016. During his more than 25 years in the pharmaceutical industry he held positions as factory manager, managing director and laboratory manager.

Under Dr Wohlers the newly created Executive Board division of Product Supply will be focused on internationalization and lean management.